Lead Nueralink scientist, Dr. Isabella Cognizant recalls the momentous occasion during the trial stages for the new device:
"After connecting the prototype device, we asked him how he felt. He responded positively, saying that he felt fine. We were astounded; it was the first straightforward answer he had ever given us."
Scientists hope that Gary can return to work as soon as the final stage trials are complete.
"We're cautiously optimistic. It would be amazing to see Chairman Gensler do his job with a working brain – fingers crossed!" Dr. Cognizant told reporters.
Contract Address (ERC-20)